Introduction
Several studies in genetically engineered animal models have documented that lack of subcutaneous and visceral fat is associated with severe insulin resistance and fat accumulation in insulin-sensitive tissues. 1 For example, A-ZIP/F-1 mice, which have no white adipose tissue subcutaneously or elsewhere, have dramatically reduced brown fat, severe hepatosteatosis, diabetes, and elevated glucose, insulin, triglyceride and free fatty acid concentrations. Transplantation of wild-type adipose tissue into these mice reverses hyperglycemia, decreases insulin concentrations, corrects insulin signaling defects and normalizes fat content in the liver and muscle. 2 This implies that fat accumulation in insulin-sensitive tissues indeed can cause insulin resistance, although the stored triglyceride itself is likely to be inert. These data in mice appear relevant for humans since highly active antiretroviral therapyassociated lipodystrophy as well as more rare forms of human lipoatrophies have uniformly been associated with a fatty liver. 3 Although fat accumulation in the liver seems important for the development of insulin resistance, other studies suggest that myeloid cells are a prerequisite for development of insulin resistance in insulin-sensitive tissues. Mice lacking IkB kinaseb, a central coordinator of inflammatory responses through activation of NF-kB in myeloid cells (macrophages and neutrophils), are protected from insulin resistance in skeletal muscle and the liver. 4 In humans, the number of macrophages and expression of macrophage markers such as CD68 are increased in obese and lipoatrophic insulinresistant subjects. [5] [6] [7] Macrophages are the major source of both IL-6 and tumor necrosis factor a (TNF-a) in adipose tissue. 6, [8] [9] [10] [11] These cytokines can induce insulin resistance locally in adipose cells via downregulation of adipokines such as adiponectin 12, 13 which is abundantly secreted systematically and has insulin-sensitising properties especially in the liver. 14, 15 Expression of the enzyme converting cortisone to cortisol, 11b-HSD-1, is also increased in insulinresistant obese subjects. 16, 17 This enzyme is expressed in both adipocytes and macrophages. 18, 19 Its overexpression in mice results in insulin resistance and visceral obesity. 20 Human fat cells, unlike those of mice, do not produce resistin 21 but resistin has been suggested to be produced by human peripheral blood mononuclear cells. 22 Unlike in mice, resistin may not, however, be related to insulin sensitivity in humans. 23, 24 Until now, only one study has explored the possibility that adipose tissue inflammation is related to hepatic lesions in obesity in humans. 25 This study included a group of morbidly obese nondiabetic and diabetic subjects. The number of macrophages in omental but not subcutaneous fat was found to be correlated with histological liver pathology other than hepatic steatosis. Insulin sensitivity was not directly quantitated. There are no studies examining the relationship between adipose tissue inflammation and liver fat content in non-obese and nonmorbidly obese subjects.
In the present study, we determined whether expression of the macrophage markers and of TNF and HSD11B1 in subcutaneous adipose tissue is related to liver fat content measured by proton spectroscopy and to whole body insulin sensitivity measured by the euglycemic insulin clamp technique. We also determined whether such relationships are independent of obesity. Since it has been suggested that susceptibility genes for insulin action may even reside in myeloid cells, 4 we also compared expression of TNF, HSD11B1 and gene encoding resistin (RETN) in cultured blood monocyte-derived macrophages.
Methods
Subjects and study designs Subjects. To determine the relationship between adipose tissue inflammation, liver fat content and insulin sensitivity, 20 nondiabetic apparently healthy Caucasian women were recruited based on the following inclusion criteria: (1) age 18-60 years, (2) no known acute or chronic disease other than obesity based on history, physical examination and standard laboratory tests (blood counts, serum creatinine, thyroid-stimulating hormone, electrolyte concentrations and electrocardiogram). Other exclusion criteria included pregnancy or treatment with drugs that may alter glucose tolerance. In each subject, a needle biopsy of adipose tissue was taken for measurement of gene expression and liver fat content was measured with proton spectroscopy and whole body insulin sensitivity using the euglycemic insulin clamp technique (insulin infusion rate 1 mU/kg/min for 2 h). In addition, a separate blood sample was taken for isolation of peripheral blood monocytes. The subjects were divided based on their median body mass index (BMI) into obese/overweight (BMI428 kg/m 2 , n ¼ 10) and non-obese (BMIo28 kg/m 2 , n ¼ 10) groups. Gene expression of TNF, HSD11B1, CD68 and ITGAM was measured in adipose tissue and in unstimulated monocyte-derived macrophages. These subjects also participated in a study 26 examining effects of a 6 h insulin infusion on adipose tissue gene expression measured at 0, 3 and 6 h. Data on liver fat and monocyte-derived macrophages are novel. In addition to these measurements, gene expression of TNF, HSD11B1 and RETN was measured basally and after 3 and 6 h of lipopolysaccharide (LPS) stimulation in 14 women, which were recruited using the same inclusion and exclusion as mentioned above and divided into obese/overweight (BMI428 kg/m 2 , n ¼ 7) and non-obese (BMIo28 kg/m 2 , n ¼ 7) groups. An age-matched pair (one obese/overweight and one non-obese subject) was studied on the same day. A blood sample was taken for differentiation of peripheral blood monocytes into macrophages (see below). Macrophages were stimulated with either LPS or saline. The nature and potential risks of the study were explained to all subjects before obtaining their written informed consent. The ethics committees of the Helsinki University Central Hospital and Karolinska Institutet approved the protocol.
Adipose tissue biopsy and total RNA and cDNA preparation A needle aspiration biopsy of abdominal subcutaneous fat was taken before insulin infusion under local anesthesia. 27 The fat sample was immediately frozen and stored in liquid nitrogen until analysis. Frozen fat tissue samples (50-150 mg) were homogenized in 2 ml RNA STAT-60 (Tel-Test, Friendswood, TX, USA) and total RNA isolated according to the manufacturer's instructions. After DNase treatment (RNase-free DNase set, Qiagen, Hilden, Germany), RNA Macrophages, obesity, liver fat content and insulin resistance J Makkonen et al was purified using the RNeasy minikit (Qiagen, Hilden, Germany). RNA concentrations were measured using the RiboGreen fluorescent nucleic acid stain (RNA quantification kit, Molecular Probes, Eugene, OR, USA) and Light Cycler (Roche Diagnostics GmbH, Mannheim, Germany). The quality of RNA was checked by agarose gel electrophoresis. Isolated RNA was stored at À801C until qualification of the target mRNAs. A total of 0.1 mg RNA was reverse transcribed into cDNA using Moloney murine leukemia virus reverse transcriptase (Life Technologies, Paisley, UK) and oligo (dT) [12] [13] [14] [15] [16] [17] [18] primers.
Quantification of mRNA concentrations mRNA expression levels of TNF, HSD11B1, CD68, RETN and ribosomal protein large P0 (RPLP0) were quantified by realtime PCR using the ABI 7000 Sequence Detection System instrument and software (Applied Biosystems, Foster City, CA, USA). cDNA synthesized from 15 ng of total RNA was mixed with TaqMan Universal PCR Master Mix (Applied Biosystems) and a gene-specific primer and probe mixture (predeveloped TaqMan Gene Expression Assays, Applied Biosystems). The assays used were TNF, Hs00174128_m1; HSD11B1, Hs00194153_m1; CD68, Hs00154355_m1; IT-GAM, Hs00355885_m1; RETN, Hs00220767_m1 and RPLP0, Hs99999902_m1. All samples were run in duplicate. Relative expression levels were determined using a five-point serially diluted standard curve, generated from cDNA from either human adipose tissue or monocyte-derived macrophages (depending on the samples being analyzed). Expression levels were expressed in arbitrary units and normalized relative to the housekeeping gene RPLP0 to compensate for differences in cDNA loading. The levels of RPLP0 were comparable between non-obese and obese subjects in both studies.
Liver fat content Liver fat content was measured using magnetic resonance proton spectroscopy as previously described. 28 Whole body insulin sensitivity Whole body insulin sensitivity was measured using the insulin clamp technique. 29 The study started at 0730 after an overnight fast. Two 18-gauge catheters (Venflon; ViggoSpectramed, Helsingborg, Sweden) were inserted, one in an antecubital vein for infusion of insulin and glucose, and another retrogradely in a heated hand vein to obtain arterialized venous blood for measurement of glucose concentrations every 5 min and serum-free insulin concentration every 30 min. Regular human insulin (Insulin Actrapid, Novo Nordisk, Denmark) was infused in a primed-continuous fashion. The rate of the continuous insulin infusion was 1 mU/kg/min for 2 h. Normoglycemia was maintained by adjusting the rate of a 20% glucose infusion based on plasma glucose measurements from arterialized venous blood every 5 min. Whole body insulin sensitivity was determined from the glucose infusion rate, corrected for changes in glucose pool size (M-value), required to maintain normoglycemia between 30 and 120 min. 29 The
M-value was expressed as mg/kg fat free mass per per minute.
Isolation and culture of macrophages Preparation of macrophage monolayers. For the in vitro studies assessing basal and LPS-stimulated gene expression, blood was drawn after an overnight fast. Human monocytes were isolated from buffy coats by centrifugation in Ficoll-Paque (Amersham Bioscience AB, Uppsala, Sweden) gradient as described. 30 Washed cells were suspended in Macrophage-SFM Medium (Gibco, Invitrogen Corporation, Grand Island, NY, USA) containing streptomycin and penicillin (Sigma, St Louis, MO, USA). The monocytes were counted, and seeded on plates. After 1 h, nonadherent cells were removed and granulocyte monocyte colony stimulating factor (GM-CSF) (5 ng/ml, Sigma) was added. Monocytes were then cultured for up to 7 days for differentiation into macrophages.
Stimulation of macrophages
In study II, 10 ml of LPS (10 mg/ml, LPS of Salmonella typhimurium, Sigma) or saline per 1 ml of SFM Medium/ GM-CSF was added to stimulate cultured macrophages for 3 and 6 h at þ 371C in an atmosphere containing 5% CO 2 .
Macrophage mRNA analysis Macrophage mRNA analysis was performed from cell lysates similarly as described for adipose tissue.
Other measurements Blood samples were taken after an overnight fast for measurement of plasma glucose, serum insulin, HbA 1C , serum alanine aminotransferase concentrations, serum triglyceride, total cholesterol, high-density lipoprotein (HDL) and LDL low-density lipoprotein cholesterol concentrations. The percent of body fat was determined by bioelectrical impedance analysis (BioElectrical Impedance Analyzer System model #BIA-101A; RJL Systems, Detroit, MI, USA).
31
Waist circumference was measured midway between spina iliaca superior and the lower-rib margin, and hip circumference at the level of the greater trochanters.
32
Analytical procedures Plasma glucose concentrations were measured in duplicate with the glucose oxidase method using Beckman Glucose analyzer II (Beckman Instruments, Fullerton, CA, USA). 33 Serum-free insulin concentrations were measured using the Auto-DELFIA kit from Wallac (Turku, Finland). HbA 1C was 
Results

Subject characteristics
Characteristics of the 10 non-obese and 10 obese/overweight subjects, whose adipose tissue gene expression, gene expression in monocyte-derived macrophages, liver fat content and in vivo insulin sensitivity were measured, are given in Table 1 . Liver fat content and markers of insulin resistance, including serum fasting insulin and triglyceride concentrations were higher and the HDL cholesterol concentration was lower in the obese/overweight compared to the non-obese group (Figure 1 
Relationship between markers of adipose tissue inflammation, liver fat and insulin sensitivity
The relationships between adipose tissue gene expression and measures of whole body insulin sensitivity, liver fat content and BMI are shown in Figure 2 . Both CD68 and HSD11B1 expression in adipose tissue were inversely correlated with whole body insulin sensitivity and positively correlated with percent liver fat and MBI (Figure 2 ). ITGAM expression in adipose tissue correlated positively with percent liver fat (r ¼ 0.67, Po0.01). Adipose tissue CD68 expression also correlated positively with those of TNF and HSD11B1 ( Figure 3 ). The expression of two macrophage markers in adipose tissue, CD68 and ITGAM, was closely correlated (r ¼ 0.81, Po0.0001). In multiple linear regression analysis, liver fat was independent of BMI and significantly associated with expression of CD68, ITGAM and HSD11B1 in adipose tissue (Table 2) . Table 1 Clinical and biochemical characteristics of the non-obese and obese/overweight groups In these subjects, a blood sample was taken to study gene expression basally and after stimulation with LPS in monocyte-derived macrophages.
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Gene expression in monocyte-derived macrophages
In monocyte-derived macrophages, there were no differences between the obese/overweight and non-obese groups regarding TNF (37.4712.6 vs 37.875.6, obese/overweight vs non-obese, NS), CD68 (1.270.1 vs 1.270.1, obese/overweight vs non-obese, NS) or HSD11B1 (0.770.1 vs 0.570.1, obese/overweight vs non-obese, NS) expression. In the obese/overweight and non-obese subjects, whose macrophages were stimulated with LPS, TNF expression increased significantly from basal to 3 h and from basal to 6 h in both non-obese and obese/overweight groups ( Figure 4) . The increase was similar in both groups. RETN expression remained unchanged with no differences between the groups (Figure 4 ). LPS also increased HSD11B1 expression Figure 1 Liver fat content, fasting serum insulin, triglycerides and HDL cholesterol in 10 non-obese (white bars) and 10 obese/overweight (black bars) subjects.
*Po0.05, **Po0.001 for non-obese vs obese/overweight. Figure 2 The relationships (r denotes Spearman's rank correlation coefficient) between adipose tissue expression of CD68 and HSD11B1 with BMI (upper panels), with whole body insulin sensitivity (M-value) (middle panels) and with % liver fat (lower panels). Expression levels are given relative to the housekeeping gene RPLP0. Macrophages, obesity, liver fat content and insulin resistance J Makkonen et al significantly and similarly in the obese/overweight and non-obese groups (Figure 4 ). There were no changes in gene expression after saline stimulation.
Discussion
In the present study, we confirmed increased expression of the macrophage markers CD68 and ITGAM, and of HSD11B1 in human adipose tissue in obese/overweight as compared to non-obese subjects. The novel finding was that these changes were associated with liver fat content and whole body insulin sensitivity. These relationships were shown to be independent of obesity. We found no alterations in expression of TNF, HSD11B1 or RETN in monocyte-derived macrophages between obese/overweight and non-obese subjects.
In keeping with most, 16 Hence increased HSD11B1 gene expression may increase local corticosteroid concentrations in subcutaneous adipose tissue. Overexpression of HSD11B1 selectively in adipose tissue in transgenic mice results in visceral obesity, insulin resistance, diabetes and hyperlipidemia. 45 The cell type responsible for HSD11B1 overexpression in obesity cannot be determined from the present data. HSD11B1 knockout mice have lower RETN and TNF mRNA levels in adipose tissue than wild-type mice. 46 If mouse data were applicable to humans, one might have expected TNF expression to be increased in adipose tissue from obese/ overweight subjects in the current study. Also, the increased CD68 expression would be expected to be accompanied by a significant increase in TNF expression. Although TNF was increased, the increase was not statistically significant. This could have been a type 2 error or, alternatively, due to phenotypic differences in macrophages. As reviewed elsewhere, 47, 48 activated macrophages produce high amounts of proinflammatory cytokines such as TNF-a while apoptotic cell engulfment appears to signal macrophages to transform into a reparative population which expresses less proinflammatory cytokines. 49 Regarding resistin, we confirm resistin expression in human macrophages 50 but found no difference in resistin expression in macrophages between obese/overweight and non-obese subjects. Although resistin has proinflammatory properties and stimulates TNF-a and IL-6 production in human peripheral blood mononuclear cells, 22 RETN expression in adipose tissue or muscle does not differ between insulin-resistant and insulin-sensitive subjects. [51] [52] [53] Expression of the macrophage marker CD68 and the percentage of CD68-positive cells has been shown to be increased in obese adipose tissue, 5, 6 but CD68 expression has previously neither been shown to be related to whole body insulin resistance or liver fat content, nor to expression of TNF and HSD11B1 in adipose tissue. These relationships may reflect a role of adipose tissue inflammation, rather than Figure 4 The expressions of TNF, RETN and HSD11B1 in monocyte-derived macrophages at 0, 3 and 6 h after LPS stimulation in non-obese (white bars) and obese/overweight subjects (black bars). *Po0.05, **Po0.01 for comparison between time points. Expression levels are given relative to housekeeping gene RPLP0.
Macrophages, obesity, liver fat content and insulin resistance J Makkonen et al peripheral fat, in regulating hepatic insulin sensitivity, since liver fat and the number of adipose tissue macrophages are also increased in patients with subcutaneous lipoatrophy. 28, 54, 55 In obese mice, deletion of either the monocytes chemoattractant protein-1 (MCP-1 or CCL2) gene 56 or its receptor (CCR2) 57 are associated with reduction in the number of macrophages in adipose tissue and liver fat content. Only one previous human study has examined the relationship between adipose tissue inflammation and liver abnormalities. Cancello et al. 25 found no relationship between the number of macrophages in subcutaneous adipose tissue and liver fat content in morbidly obese subjects. The number of macrophages in omental adipose tissue correlated with liver histologic lesions but not with liver fat. 25 No healthy lean controls were included in this study. A limitation of our study is that we measured gene expression of two macrophage markers but could not perform immunohistochemical studies because a needle rather than surgical biopsy of adipose tissue was taken.
The studies showing macrophage infiltration in human and murine adipose tissue 5, 6 and that mice lacking IkB kinaseb are protected from insulin resistance in skeletal muscles and the liver 4 raised the interest in exploring the role of myeloid cells in the pathogenesis of insulin resistance in humans. Early studies suggested that insulin receptor tyrosine kinase activity is low in freshly isolated monocytes from non-obese insulin-resistant as compared to sensitive subjects. 58 Mononuclear cell adhesion to the endothelium has also been found to correlate with the degree of insulin resistance. 59 Recently, freshly isolated circulating monocytes were suggested to be in a proinflammatory state in obese subjects compared to normal-weight controls. 60 These data do not necessarily disagree with the present findings of unaltered basal and stimulated expression of insulin resistance genes in monocyte-derived macrophages, since we did not study freshly isolated monocytes in which gene expression reflects both acquired and genetic factors. Obviously this warrants isolation of macrophages from adipose tissue and measurement of a larger number of genes as well as a direct assessment of the macrophage fraction.
In conclusion, in keeping with previous data the expression of macrophage markers is increased in obese human adipose tissue. This sign of inflammation is correlated with liver fat content independent of obesity. Liver fat content in turn is correlated with serum insulin and other signs of insulin resistance. These data may help to understand why only some but not all obese subjects develop signs of insulin resistance.
